HOME >> BIOLOGY >> NEWS
Miniature spectrometer can detect biological hazards

OAK RIDGE, Tenn., March 17, 2003 Researchers at the Department of Energy's Oak Ridge National Laboratory have developed a miniature device that can identify as little as a fraction of a spore of anthrax and other biological hazards within 30 milliseconds.

The Calorimetric Spectrometer (CalSpec TM) device technology can accurately identify biological hazards such as anthrax almost instantly. The device can operate with only a fraction of a spore while isolating the DNA/RNA photothermal signature that allows for detection, identification and measurement of a substance.

Such prompt detection and identification of hazardous materials could greatly enhance the protection of first-responder emergency personnel and the capabilities of early warning systems. Current technologies do not provide the level of sensitivity offered by the CalSpec TM chemical, biological and DNA/RNA detection system.

Researchers Panos Datskos and Slobodan Rajiic of ORNL's Engineering Science and Technology Division developed the CalSpec TM technology. ORNL has licensed the technology exclusively to Innovative American Technology of Herndon, Va., and Boca Raton, Fla.

The CalSpec TM can detect hazards by identifying their molecules. The molecular absorption can induce stress changes that allow for an initial detection that can be used for measurement. The identification of chemical and/or biological molecules, along with DNA/RNA, creates a photothermal signature.

The spectrometer could have a wide variety of applications in commercial industry and in homeland defense, including mass transit and airport security; in the postal industry, to protect workers and the public; and in monitoring air quality systems.

"The CalSpec TM detection device could provide a cost-effective and easily deployed upgrade for these systems to enable rapid detection, greater accuracy and most important increased sensitivity down to a fraction of a spore," said Jack Cumming
'"/>


17-Mar-2003


Page: 1 2

Related biology news :

1. Miniature biolab embedded on silicon chip
2. Miniature implantable sensor likely lifesaver for patients
3. Scientists Excited About Miniature Cooking Pots
4. Collaboration at EMSL produces innovative mass spectrometer
5. Mass spectrometer weighs in as proteomics breakthrough
6. The worlds most powerful NMR spectrometer
7. New sequence involved in DNA replication timing may aid in cancer detection
8. Scientists find nanowires capable of detecting individual viruses
9. Brain has center for detecting sound motion
10. Early detection hope for eye disease
11. Wrapping a memory with an experience, capacity for recollection detected in non-human species

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Miniature spectrometer can detect biological hazards

(Date:6/23/2015)... GARDENS, Fla. , June 23, 2015 ... identity management and authentication solutions, today announced enhanced ... strong, multi-factor authentication solution.  The enhancements build ... use of the DigitalPersona Altus platform and ... reader compatibility. In today,s environment ...
(Date:6/17/2015)... GERMANTOWN, Maryland , June 17, 2015 /PRNewswire/ ...   Produktlinie mit DNA-Tests verbessert den Analyseprozess und senkt ... ; Frankfurt Prime Standard: QIA) hat heute in den ... Investigator ® für die ... neuen Kits zur Erstellung genetischer Fingerabdrücke bieten eine integrierte ...
(Date:6/17/2015)... BEACH GARDENS, Fla. , June 17, 2015 ... management solutions, today announced that its U.are.U ® ... Togo,s Eateries, Inc., a ... fast casual sandwich chain, to increase security, improve ... Crossmatch fingerprint readers enable instant, non-repudiable identity confirmation ...
Breaking Biology News(10 mins):Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 4QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 5QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 6Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 2Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 3
(Date:7/2/2015)... ... July 02, 2015 , ... ... of surgical instruments in Orthopedics, announced today the acquisition of Turner Medical, ... largest provider of surgical instruments to the Spine Industry. The acquisition of Turner ...
(Date:7/1/2015)... BURLINGTON, Mass. , July 1, 2015 /PRNewswire/ ... three most frequently cited advantages of Otezla are ... favorable safety profile, as reported by surveyed rheumatologists. ... and launched for the treatment of active psoriatic ... . The current standard of care includes conventional ...
(Date:7/1/2015)... July 1, 2015   Neuraltus Pharmaceuticals, Inc. ... of groundbreaking drugs to treat neurodegenerative diseases such ... Robert G. Miller , M.D., Director of the ... California Pacific Medical Center in San Francisco, has been ... $1.5 million to help fund a Phase 2 ...
(Date:7/1/2015)... ... July 01, 2015 , ... A newly launched business ... to lower the barriers to innovation in life sciences R&D. The Pistoia Alliance President’s ... cash prizes of US$15,000 and a period of expert mentorship from a senior industry ...
Breaking Biology Technology:In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3
Cached News: